| mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.9 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |